• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一万例连续胃癌胃切除术:一位外科大师的观点

Ten Thousand Consecutive Gastrectomies for Gastric Cancer: Perspectives of a Master Surgeon.

作者信息

Choi Yoon Young, Cho Minah, Kwon In Gyu, Son Taeil, Kim Hyoung Il, Choi Seung Ho, Cheong Jae Ho, Hyung Woo Jin

机构信息

Department of Surgery, Yonsei University Health System, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Yonsei Med J. 2019 Mar;60(3):235-242. doi: 10.3349/ymj.2019.60.3.235.

DOI:10.3349/ymj.2019.60.3.235
PMID:30799586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6391520/
Abstract

As radical gastrectomy with lymph node dissection is currently the best strategy to cure gastric cancer, the role of the surgeon remains quite important in conquering it. Dr. Sung Hoon Noh, a surgeon and surgical oncologist specializing in gastric cancer, has treated gastric cancer for 30 years and has conducted over 10000 cases of gastrectomy for gastric cancer. He first adapted an electrocautery device into gastric cancer surgery and has led standardization of surgical procedures, including spleen preserving gastrectomy. His procedures based on patient-oriented insights have become the basis of the concept of enhanced recovery after surgery. He has also contributed to improving patient's survival through adoption of a multidisciplinary approach: he proved the benefit of adjuvant chemotherapy after radical D2 gastrectomy for stage II/III gastric cancer in clinical trials, updating treatment guidelines throughout the world. Dr. Noh also opened the era of precision medicine for treating gastric cancer, as he developed and validated a mRNA expression based algorithm to predict prognosis and response to chemotherapy. This article reviews his contribution and long history of service in the field of gastric cancer. The perspectives of this master surgeon, based on his profound experience and insights, will outline directions for integrative multidisciplinary health care and how can surgeons prepare for the future.

摘要

由于根治性胃切除术加淋巴结清扫术目前是治愈胃癌的最佳策略,外科医生在攻克胃癌方面的作用仍然相当重要。Sung Hoon Noh博士是一位专门从事胃癌治疗的外科医生和外科肿瘤学家,他治疗胃癌已有30年,进行了超过10000例胃癌胃切除术。他首先将电灼设备应用于胃癌手术,并主导了包括保留脾脏胃切除术在内的手术程序标准化。他基于以患者为导向的见解所开展的手术已成为术后加速康复概念的基础。他还通过采用多学科方法为提高患者生存率做出了贡献:他在临床试验中证明了II/III期胃癌根治性D2胃切除术后辅助化疗的益处,更新了全球的治疗指南。Noh博士还开创了胃癌精准医疗的时代,他开发并验证了一种基于mRNA表达的算法来预测预后和化疗反应。本文回顾了他在胃癌领域的贡献和悠久的服务历史。这位主刀医生基于其丰富经验和深刻见解的观点,将概述综合多学科医疗保健的方向以及外科医生如何为未来做好准备。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca6a/6391520/1ad08524d54a/ymj-60-235-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca6a/6391520/ab63f0ab55e9/ymj-60-235-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca6a/6391520/1ad08524d54a/ymj-60-235-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca6a/6391520/ab63f0ab55e9/ymj-60-235-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca6a/6391520/1ad08524d54a/ymj-60-235-g002.jpg

相似文献

1
Ten Thousand Consecutive Gastrectomies for Gastric Cancer: Perspectives of a Master Surgeon.一万例连续胃癌胃切除术:一位外科大师的观点
Yonsei Med J. 2019 Mar;60(3):235-242. doi: 10.3349/ymj.2019.60.3.235.
2
[Discussion on standardized implementation of laparoscopic radical lymphadenectomy for distal gastric cancer].[关于远端胃癌腹腔镜根治性淋巴结清扫术标准化实施的探讨]
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Aug 25;20(8):857-861.
3
[Individualized surgery for gastric cancer].[胃癌的个体化手术]
Korean J Gastroenterol. 2011 Jun;57(6):335-9. doi: 10.4166/kjg.2011.57.6.335.
4
Robotic D2 Lymph Node Dissection During Distal Subtotal Gastrectomy for Gastric Cancer: Toward Procedural Standardization.胃癌远端次全胃切除术中机器人D2淋巴结清扫:迈向手术标准化
Ann Surg Oncol. 2016 Aug;23(8):2409-10. doi: 10.1245/s10434-016-5166-7. Epub 2016 Mar 8.
5
[Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].[胃癌全胃切除术:淋巴结清扫类型会影响长期疗效吗?]
Suppl Tumori. 2005 May-Jun;4(3):S84-5.
6
Learning curve for gastric cancer surgery based on actual survival.基于实际生存率的胃癌手术学习曲线
Gastric Cancer. 2016 Apr;19(2):631-638. doi: 10.1007/s10120-015-0477-0. Epub 2015 Feb 25.
7
[Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].[胃癌根治性胃切除术联合脾切除术的长期疗效分析]
Zhonghua Wai Ke Za Zhi. 2005 Sep 1;43(17):1114-7.
8
Resection for gastric cancer in the community.社区胃癌切除术
Semin Oncol. 2005 Dec;32(6 Suppl 9):S90-3. doi: 10.1053/j.seminoncol.2005.06.010.
9
Lymph node dissection in resectable advanced gastric cancer.可切除的进展期胃癌的淋巴结清扫。
Dig Surg. 2013;30(2):96-103. doi: 10.1159/000350873. Epub 2013 Jul 18.
10
[Clinical research status of laparoscopic gastric cancer surgery in China, Japan and South Korea].[中国、日本和韩国腹腔镜胃癌手术的临床研究现状]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Feb 25;21(2):126-131.

引用本文的文献

1
The clinical outcome of minor changes in serum creatinine for patients after curative gastrectomy: a prospective study.胃癌根治术后患者血清肌酐微小变化的临床结局:一项前瞻性研究。
Front Oncol. 2024 Aug 21;14:1416888. doi: 10.3389/fonc.2024.1416888. eCollection 2024.
2
Surgical starting time of the day and survival in gastric cancer.一天中手术开始时间与胃癌患者的生存情况。
Sci Rep. 2023 Apr 28;13(1):6955. doi: 10.1038/s41598-023-33692-0.
3
Current Trends in Volume and Surgical Outcomes in Gastric Cancer.胃癌手术量及手术结果的当前趋势

本文引用的文献

1
Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial.单患者分类分析、微卫星不稳定性和爱泼斯坦-巴尔病毒状态预测II/III期胃癌的临床结局:CLASSIC试验结果
Yonsei Med J. 2019 Feb;60(2):132-139. doi: 10.3349/ymj.2019.60.2.132.
2
Comment on "To Treat, or Not to Treat, That is the Question: Biomarker-guided Adjuvant Chemotherapy for Stage II and III Gastric Cancer".对《治疗还是不治疗,这是个问题:生物标志物指导的II期和III期胃癌辅助化疗》的评论
Ann Surg. 2019 Aug;270(2):e40-e41. doi: 10.1097/SLA.0000000000003102.
3
J Clin Med. 2023 Apr 4;12(7):2708. doi: 10.3390/jcm12072708.
4
Utility of Pretreatment Blood Platelet-To-Lymphocyte Ratio in Prediction of Clinical Outcomes and Chemosensitivity in Patients with Advanced Gastric Cancer: A Meta-Analysis.术前血小板与淋巴细胞比值对晚期胃癌患者临床结局和化疗敏感性的预测价值:Meta 分析。
Med Sci Monit. 2022 Jan 31;28:e933449. doi: 10.12659/MSM.933449.
5
A study of outcomes, technical safety, and feasibility of D-2 lymphadenectomy in gastric cancer.胃癌D2淋巴结清扫术的疗效、技术安全性及可行性研究
JGH Open. 2020 Aug 8;4(6):1114-1118. doi: 10.1002/jgh3.12402. eCollection 2020 Dec.
6
Clinical Implications of Microsatellite Instability in Early Gastric Cancer.早期胃癌中微卫星不稳定性的临床意义
J Gastric Cancer. 2019 Dec;19(4):427-437. doi: 10.5230/jgc.2019.19.e38. Epub 2019 Nov 8.
Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy.
多学科治疗方案在 IV 期胃癌患者中的应用:化疗后转化手术的作用。
BMC Cancer. 2018 Nov 15;18(1):1116. doi: 10.1186/s12885-018-4998-x.
4
Fluorescent Lymphography-Guided Lymphadenectomy During Robotic Radical Gastrectomy for Gastric Cancer.荧光淋巴显影引导下的机器人胃癌根治术淋巴结清扫术。
JAMA Surg. 2019 Feb 1;154(2):150-158. doi: 10.1001/jamasurg.2018.4267.
5
Modification of the TNM Staging System for Stage II/III Gastric Cancer Based on a Prognostic Single Patient Classifier Algorithm.基于单患者预后分类算法对Ⅱ/Ⅲ期胃癌TNM分期系统的修正
J Gastric Cancer. 2018 Jun;18(2):142-151. doi: 10.5230/jgc.2018.18.e14. Epub 2018 May 31.
6
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.基于 21 基因表达检测的乳腺癌辅助化疗。
N Engl J Med. 2018 Jul 12;379(2):111-121. doi: 10.1056/NEJMoa1804710. Epub 2018 Jun 3.
7
Reduced-port totally robotic distal subtotal gastrectomy with lymph node dissection for gastric cancer: a modified technique using Single-Site and two additional ports.经脐单部位及两个辅助操作孔完全腹腔镜胃癌远端胃大部切除术: 一种使用单部位和两个附加操作孔的改良技术。
Surg Endosc. 2018 Aug;32(8):3713-3719. doi: 10.1007/s00464-018-6208-y. Epub 2018 May 18.
8
Selective Cytotoxicity of the NAMPT Inhibitor FK866 Toward Gastric Cancer Cells With Markers of the Epithelial-Mesenchymal Transition, Due to Loss of NAPRT.NAMPT 抑制剂 FK866 对具有上皮-间充质转化标志物的胃癌细胞的选择性细胞毒性,归因于 NAPRT 的缺失。
Gastroenterology. 2018 Sep;155(3):799-814.e13. doi: 10.1053/j.gastro.2018.05.024. Epub 2018 Jul 30.
9
Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer: Post Hoc Analysis of the CLASSIC Randomized Controlled study.Ⅱ/Ⅲ 期胃癌中微卫星不稳定性和程序性死亡配体 1 表达:CLASSIC 随机对照研究的事后分析。
Ann Surg. 2019 Aug;270(2):309-316. doi: 10.1097/SLA.0000000000002803.
10
Precision medicine in the adjuvant treatment of gastric cancer.精准医学在胃癌辅助治疗中的应用
Lancet Oncol. 2018 May;19(5):583-584. doi: 10.1016/S1470-2045(18)30131-1. Epub 2018 Mar 19.